Aurobindo To Acquire Generics Company
By

By
Aurobindo Pharma, a generics and active pharmaceutical ingredients (API) manufacturer headquartered in Hyderabad, India has signed a binding agreement by and through its wholly owned ubsidiary, Agile Pharma B.V, Netherlands,…

Aerie Pharmaceuticals Plans Manufacturing Plant in Ireland
By

By
Aerie Pharmaceuticals, an Irvine, California-headquartered clinical-stage pharmaceutical company focused on glaucoma and other eye diseases, has entered into a lease agreement with the Industrial Development Agency (IDA) of Ireland for…

Merck KGaA Names New Chief Procurement Officer
By

By
Merck KGaA has appointed Joachim Christ as its new chief procurement officer (CPO), succeeding Friedhelm Felten in that role. Mr. Christ is currently head of Group Controlling & Risk Management.…

Biogen in $1.25 Billion Settlement and License Agreement
By

By
Biogen has agreed to a settlement and license agreement with Forward Pharma, a Copenhagen, Denmark-headquartered biopharmaceutical company, with respect to a patent dispute over intellectual property covering dimethyl fumarate, the…

Pfizer Opens Manufacturing Plant in Saudi Arabia
By

By
Pfizer Saudi Limited, a subsidiary of Pfizer, has opened a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia and has begun operations for producing 16 medicines at the plant.…

Amgen Signs Deal for Pain-Drug Portfolio
By

By
Amgen has boosted its pain-drug portfolio by signing a deal with SiteOne Therapeutics, a pharmaceutical company headquartered in Bozeman, Montana that focuses on pain therapeutics. The agreement combines SiteOne’s drug…

Amgen Granted Cholesterol-Drug Injunction, Sanofi to Appeal
By

By
Amgen has been granted a permanent injunction by the United States District Court in Delaware that prohibits Sanofi and its partner, Regeneron Pharmaceuticals, from infringing two patents that Amgen holds…

2016 NME Drug Approvals Drop After Recent Highs
By

By
Following two consecutive years of high numbers in new molecular entity (NME) approvals by the US Food and Drug Administration’s Center for Drug Evaluation and Research, NME approvals in 2016…

Sanofi Extends Collaboration for Cardiovascular Therapies
By

By
Sanofi has extended its cardiomyopathy research collaboration with MyoKardia, a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, triggering a $45-million milestone payment to MyoKardia payable by January 31,…

BMS, Janssen in Immunotherapy Pact
By

By
Bristol-Myers Squibb (BMS) has formed a new clinical research collaboration with Janssen Biotech, a Johnson & Johnson company, to evaluate the combination of BMS’s immuno-oncology agent, Opdivo (nivolumab), and Janssen’s…